Company Eisai Co., Ltd.

Equities

4523

JP3160400002

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-03-29 am EDT 5-day change 1st Jan Change
6,216 JPY -0.24% Intraday chart for Eisai Co., Ltd. -2.51% -11.85%

Business Summary

Eisai Company specializes in the manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical products (87.7%): prescribed drugs, health products, etc.;

- other (12.3%): food additives, chemical products, etc.

Net sales are distributed geographically as follows: Japan (46.2%), Europe (19.5%), Americas (15.5%), China (10.3%) and other (8.4%).

Number of employees: 11,076

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceutical
91.9 %
626,281 82.8 % 684,434 91.9 % +9.29%
Other
8.1 %
129,945 17.2 % 59,969 8.1 % -53.85%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
33.6 %
243,385 32.2 % 250,327 33.6 % +2.85%
Americas
32.1 %
226,719 30.0 % 239,293 32.1 % +5.55%
China
14.6 %
106,592 14.1 % 108,562 14.6 % +1.85%
Europe
11.6 %
126,745 16.8 % 86,026 11.6 % -32.13%
Other
8.1 %
52,784 7.0 % 60,195 8.1 % +14.04%

Managers

Managers TitleAgeSince
Chief Executive Officer 76 75-09-30
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 65 81-03-31
Compliance Officer 59 89-03-31
Director/Board Member 64 88-03-31
Director/Board Member 66 81-03-31
Director/Board Member 66 82-03-31
Investor Relations Contact 57 90-03-31
Public Communications Contact 55 91-03-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 76 75-09-30
Director/Board Member 71 21-05-31
Director/Board Member 69 -
Director/Board Member 66 81-03-31
Director/Board Member 62 -
Director/Board Member 64 88-03-31
Director/Board Member 71 18-05-31
Director/Board Member 58 20-05-31
Director/Board Member 59 22-06-16
Director/Board Member 66 82-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 296,566,949 278,292,621 ( 93.84 %) 9,530,708 ( 3.214 %) 93.84 %

Shareholders

NameEquities%Valuation
Wellington Management Co. LLP
6.998 %
20,752,870 6.998 % 867 M ¥
Government of Japan
5.039 %
14,945,200 5.039 % 624 M ¥
9,530,200 3.214 % 398 M ¥
Nikko Asset Management Co., Ltd.
2.843 %
8,432,400 2.843 % 352 M ¥
Nippon Life Insurance Co.
2.192 %
6,500,000 2.192 % 272 M ¥
Mitsubishi UFJ Asset Management Co., Ltd.
1.622 %
4,810,600 1.622 % 201 M ¥
4,800,000 1.619 % 201 M ¥
The Naito Foundation
1.420 %
4,212,000 1.420 % 176 M ¥
1,728,796 0.5829 % 72 M ¥
1,699,673 0.5731 % 71 M ¥
NameEquities%Valuation
RhumbLine Advisers LP
0.001223 %
14,510 0.001223 % 151 571 ¥
GAMMA Investing LLC
0.000005 %
59 0.000005 % 616 ¥

Holdings

NameEquities%Valuation
9,530,200 3.21% 398,221,885 $
8,445,000 1.97% 139,988,289 $
474,000 0.96% 10,751,856 $
874,957 0.11% 10,009,508 $
11,738,243 6.85% 9,554,226 $
642,154 1.24% 5,697,736 $
349,000 0.43% 3,215,546 $
546,005 2.24% 2,918,446 $
134,748 0.06% 2,039,631 $
56,608 0.14% 180,788 $

Company contact information

Eisai Co., Ltd.

4-6-10 Koishikawa Bunkyo-Ku

112-8088, Tokyo

+81 3 3817 3700

http://www.eisai.co.jp
address Eisai Co., Ltd.(4523)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
6,231 JPY
Average target price
8,336 JPY
Spread / Average Target
+33.78%
Consensus